Immunization

Indonesia MR Vaccination Campaign: 33.1 million children vaccinated as of 26 September 2017

The Government of Indonesia on 1st August 2017 launched phase 1 of the National measles-rubella (MR) immunization campaign targeting all children in the ages group of 9 months and <15 years reflecting government commitment for measles elimination and rubella / CRS control. Over 35 million children are expected to receive the measles-rubella vaccine during the first phase of campaign, which is being conducted throughout the Java Island in the months of August and September 2017. A total of 3,569 public health centers in 119 districts spread across six provinces in Java Island are involved to vaccinate children with MR vaccine both in schools and in the communities. Children in schools received vaccination during the month of August and now in September the vaccination activities are being conducted in the communities & villages to vaccinate children aged 9 months to 5 years plus those children who missed the school doses.

As of 26 September 2017, a total of 33.1 million children i.e. 94.2 % of the total targeted children have received MR vaccine.

The MR campaign is still ongoing and aims to reach > 95% immunization coverage. The first phase of the campaign is significant as it is expected to accelerate the country’s efforts to eliminate measles and control rubella and congenital rubella syndrome in Indonesia by 2020. The campaign also marks the introduction of rubella vaccine in Indonesia EPI programme.

Measles Rubella Vaccination campaign in India - coverage as of 21st September 2017

Measles elimination and rubella/CRS control by 2020 is a Flagship Programme of WHO South-East Asia Region, and Member States – including India – have committed to achieving this goal.

A key strategy for eliminating measles and controlling rubella is achieving high vaccination coverage (at least 95%) with measles-rubella (MR) vaccine through routine immunization and supplementary mass campaigns.

Since February 2017 Government of India has pursued this outcome via a phased mass MR vaccination campaign for children from 9 months to 15 years of age.
The first phase of the campaign was completed in March 2017 in 70 districts in the states of Goa, Karnataka, Lakshadweep, Puducherry and Tamil Nadu. The vaccination campaign achieved reported coverage of 97% of the targeted 35.8 million children.

The second phase of the MR campaign was launched in August in Andhra Pradesh, Chandigarh, Dadra, Nagar Haveli, Daman & Diu, Telangana and Himachal Pradesh. The campaign in Kerala and Uttarakhand will commence in October 2017. A total of 34.1 million children are being targeted for this phase of the campaign.

Presented and released as a public health achievement at 69th RC in Colombo-Sri Lanka

Maternal and neonatal (MNT), a consequence of inadequate maternal protection with anti-tetanus vaccine, coupled with unclean deliveries and poor umbilical cord care was once one of the most lethal infections for mothers and their newborns across the South-East Asia Region. Following more than two decades of collective efforts, however, the WHO-South-East Asia Region was in May 2016 validated as having eliminated the deadly disease.
The 11 Member States of the South-East Asia Region, along with the thousands of frontline health workers, volunteers and community members that were a part of the elimination efforts, are commended for their hard work and dedication to overcoming the many challenges confronted over the years.

WHO South-East Asia Region eliminates maternal and neonatal tetanus

WHO SEARO

Home to nearly one-fourth of the global population, the South-East Asia Region has eliminated maternal and neonatal tetanus with the cases reduced to less than one per 1 000 live births in all districts across the 11 countries. MNTE for the Region became official after a team of experts validated the remaining provinces of ‪‎Indonesia. SEAR is the second region to achieve MNTE after the European Region.

Recent Events

fact buffet

Children immunized in SEAR

32.3 millionagainst diphtheria, tetanus and pertussis in 2016

Regional immunization data

Wild poliovirus cases in SEAR

Zerosince 13 January 2011

India continues polio-free

Children missed in SEAR

4.4 millionfrom immunization against diphtheria, tetanus and pertussis in 2016

Year of Intensification of Routine Immunization

Meetings and events

Contact

Immunization and Vaccine Development
WHO Regional Office for South-East Asia
Indraprastha Estate
Mahatma Gandhi Marg
New Delhi 10002

Telephone: +91 11 2337 0804
Fax: +91 11 2337 0106
Email: searivd@who.int